Treatment

Multiple ascending doses of QRL-201 clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE1
A Study Evaluating the Safety and Tolerability of QRL-201 in ALS
This study is looking at a new medicine called QRL-201 for people with Amyotrophic Lateral Sclerosis (ALS). Researchers want to see if it's safe and how well people tolerate different doses. It's an early-stage study to understand the medicine better.
For: Amyotrophic Lateral Sclerosis
Belgium · Canada · Germany